AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Esomeprazole Magnesium Dihydrate Equivalent To Esomeprazole

11 registrations across 1 African market— 8 active

Markets with Esomeprazole Magnesium Dihydrate Equivalent To Esomeprazole

Recent registrations

Brand / ProductMarketHolderStatusExpires
EMANERA 20 mg🇿🇦South AfricaLHC Pharmaceuticals (Pty) LtdunknownOct 2029
EMANERA 40 mg🇿🇦South AfricaLHC Pharmaceuticals (Pty) LtdunknownOct 2029
NEXTELL OTC🇿🇦South AfricaAustell Pharmaceuticals (Pty) LtdactiveFeb 2029
ESOMEPRAZOLE 40 mg AUSTELL🇿🇦South AfricaAustell Pharmaceuticals (Pty) LtdsuspendedFeb 2024
ESOMEPRAZOLE 20 MG CIPLA🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
NEXGASTRO 20🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
URDALA 40🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
DISPEP 20🇿🇦South AfricaInnovata PharmaceuticalsactiveJan 1900
ESOCID OTC🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900
ESOCID 40🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveJan 1900
DISPEP 40🇿🇦South AfricaInnovata PharmaceuticalsactiveJan 1900

Esomeprazole Magnesium Dihydrate Equivalent To Esomeprazole in Africa — Regulatory Overview

Esomeprazole Magnesium Dihydrate Equivalent To Esomeprazole is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 8 (73%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.